Literature DB >> 17923461

Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation.

P P Dimitrow1, A Undas, M Bober, W Tracz, J S Dubiel.   

Abstract

OBJECTIVES: To investigate the association of left ventricular outflow tract (LVOT) obstruction with blood coagulation, platelet activity and inflammatory response in patients with hypertrophic cardiomyopathy (HCM) and sinus rhythm. PATIENTS AND MAIN OUTCOME MEASURES: In 42 patients with HCM with sinus rhythm, including 16 patients with resting LVOT obstruction (gradient > or = 30 mm Hg) and 29 age- and sex-matched controls, markers of thrombin generation (thrombin-antithrombin complex (TAT), prothrombin fragment 1+2 (F1+2)), platelet activation (soluble CD40 ligand (sCD40L), beta-thromboglobulin (beta-TG), P-selectin) and inflammation (C-reactive protein (CRP), interleukin (IL)6, tumour necrosis factor-alpha (TNFalpha)) were determined.
RESULTS: Thrombin, platelet and inflammatory markers were higher in the entire HCM group than in controls (p<0.005 for all compared parameters). Compared with non-obstructive HCM, obstructive HCM was associated with increased thrombin formation (TAT, F1+2), platelet activation (sCD40L, beta-TG, P-selectin) and both CRP and IL6 levels. Only the level of TNFalpha was similar in both forms of HCM. In contrast, a comparison of non-obstructive HCM with controls showed that all these variables (except for P-selectin) were similar; P-selectin was higher in non-obstructive HCM. The LVOT gradient correlated positively with all the raised blood markers (r from 0.39 to 0.73; p<0.05), except for TNFalpha. In multiple regression analysis models, the LVOT gradient was the only independent predictor of TAT (R(2) = 0.61; p<0.001), sCD40L (R(2) = 0.59; p<0.001), F1+2 (R(2) = 0.55; p = 0.002), P-selectin (R(2) = 0.49; p = 0.004) and beta-TG (R(2) = 0.38; p = 0.005) in patients with HCM.
CONCLUSIONS: LVOT obstruction is independently associated with enhanced thrombin generation and platelet activity in patients with HCM with sinus rhythm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923461     DOI: 10.1136/hrt.2007.126896

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  9 in total

1.  Activated factor XI and tissue factor in aortic stenosis: links with thrombin generation.

Authors:  Joanna Luszczak; Anetta Undas; Matthew Gissel; Maria Olszowska; Saulius Butenas
Journal:  Blood Coagul Fibrinolysis       Date:  2011-09       Impact factor: 1.276

2.  Pro-coaguable states lead to a sticky situation: coronary saddle embolism in a patient with known hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Daniel Keene; Amanda Varnava; Will Wallis
Journal:  BMJ Case Rep       Date:  2012-09-07

3.  Peripheral vascular endothelial function in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Craig A Napolitano; Martin S Maron; Eshan A Patvardhan; Ayan R Patel; Natesa G Pandian; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-01-01       Impact factor: 2.778

4.  Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?

Authors:  Yunhong Wang; Xuemei Zhao; Mei Zhai; Yan Huang; Qiong Zhou; Yuhui Zhang; Yi Mao; Jian Zhang
Journal:  BMC Cardiovasc Disord       Date:  2022-04-13       Impact factor: 2.298

Review 5.  Obstructive Form of Hypertrophic Cardiomyopathy-Left Ventricular Outflow Tract Gradient: Novel Methods of Provocation, Monitoring of Biomarkers, and Recent Advances in the Treatment.

Authors:  Pawel Petkow Dimitrow; Renata Rajtar-Salwa
Journal:  Biomed Res Int       Date:  2016-05-10       Impact factor: 3.411

6.  Prognostic Significance of Plasma High-Sensitivity C-Reactive Protein in Patients With Hypertrophic Cardiomyopathy.

Authors:  Ling Zhu; Yubao Zou; Yilu Wang; Xiaoliang Luo; Kai Sun; Hu Wang; Lei Jia; Yan Liu; Juan Zou; Zuyi Yuan; Rutai Hui; Lianming Kang; Lei Song; Jizheng Wang
Journal:  J Am Heart Assoc       Date:  2017-02-02       Impact factor: 5.501

7.  Association between severity of obstructive sleep apnea and high-sensitivity C-reactive protein in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Juan Wang; Haobo Xu; Chao Guo; Xin Duan; Fenghuan Hu; Weixian Yang; Jingang Cui; Lei Song; Yushi Chun; Jiansong Yuan; Shubin Qiao
Journal:  Clin Cardiol       Date:  2020-05-27       Impact factor: 2.882

Review 8.  Thromboembolism in Patients with Hypertrophic Cardiomyopathy.

Authors:  Lu Liu; Zheng Liu; Xiaoping Chen; Sen He
Journal:  Int J Med Sci       Date:  2021-01-01       Impact factor: 3.738

9.  Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis.

Authors:  Thomas Wurster; Roland Tegtmeyer; Oliver Borst; Dominik Rath; Tobias Geisler; Meinrad Gawaz; Boris Bigalke
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.